JR-AB2-011 - mTORC2-抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第1頁(yè)
JR-AB2-011 - mTORC2-抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第2頁(yè)
JR-AB2-011 - mTORC2-抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第3頁(yè)
JR-AB2-011 - mTORC2-抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEJR-AB2-011Cat. No.: HY-122022分式: CHClFNOS分量: 398.28作靶點(diǎn): mTOR作通路: PI3K/Akt/mTOR儲(chǔ)存式: 4C, protect from light* In solvent : -80C, 6 months; -20C, 1 month (protect fromlight)溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 62.5 mg/mL (156.92 mM; Need ultrasonic)H2O

2、 : 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (5.22 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.08 mg/mL (5.22 mM); Clear solutionBIOLOGICAL ACTIVITY1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE物活性 JR-AB2-011種選擇性 mTORC2 抑制劑,IC50 值為 0.36 M。JR-AB2-011 通過(guò)阻斷 Rict

3、or-mTOR 聯(lián)合體 (Ki: 0.19 M) 抑制 mTORC2 活性。JR-AB2-011 具有抗多形性膠質(zhì)母細(xì)胞瘤 (GBM) 的活性 1。IC50 & Target mTORC20.36 M (IC50)體外研究 JR-AB2-011 (1 M; 24 hours) has good anti-GBM properties, blocks mTORC2 signaling and Rictor associationwith mTOR 1.JR-AB2-011 (0.5-2 M; 48 hours) displays the least toxicity to normal neur

4、ons with no significant cytotoxiceffects for concentrations up to 10 mM compared to CID613034 1.Apoptosis Analysis 1Cell Line: U87 GBM cells; LN229 GBM cellsConcentration: 1 MIncubation Time: 24 hoursResult: Had good anti-GBM properties and blocked mTORC2 signaling and Rictor association withmTOR.Ce

5、ll Cytotoxicity Assay 1Cell Line: Normal mature human neuronsConcentration: 0.5, 1, 2 MIncubation Time: 48 hoursResult: Displayed the least toxicity to normal neurons with no significant cytotoxic effects forconcentrations up to 10 mM.體內(nèi)研究 Mice receiving JR-AB2-011 (4 mg/kg; daily i.p. for 10 days;

6、20 mg/kg; daily i.p. for 10 days) at either dosingregimen display marked inhibition of tumor growth rate (JR-AB2-011 at 4 mg/kg/d; 74% inhibition at end ofdosing period; tumor growth delay 10.0 days; JR-AB2-011 at 20 mg/kg/d; 80% inhibition at end of dosingperiod; tumor growth delay 12.0 days) as co

7、mpared to mice receiving vehicle alone 1.Animal Model: LN229 cells in female C.B.-17-scid (Taconic) mice 1Dosage: 4 mg/kg; 20 mg/kgAdministration: Daily i.p.; 10 daysResult: Either dosing regimen displayed marked inhibition of tumor growth rate as compared tomice receiving vehicle alone.REFERENCES2/

8、3 Master of Small Molecules 您邊的抑制劑師www.MedChemE1. Benavides-Serrato A, et al. Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxicinglioblastoma. PLoS One. 2019 Feb 6;14(2):e0212160.McePdfHeightCaution: Product has not been fully validated for medical applications.Fo

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論